Clinical Trial Update: First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients. [Phase 1, Phase 2]

View source ↗

Summary

First-in-man clinical study to evaluate safety and tolerability of an oncolytic adenovirus in prostate cancer patients (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Prostate
• Prostate Cancer

Drugs mentioned

• Oncolytic adenovirus (investigational, unnamed)

Snippet

Sponsor: Orca Therapeutics B.V. | Conditions: Adenocarcinoma of the Prostate | Phase 1, Phase 2 | Status: UNKNOWN